Skip to main content
Erschienen in: Journal of Gastroenterology 9/2012

01.09.2012 | Original Article—Alimentary Tract

Effects of family history on inflammatory bowel disease characteristics in Japanese patients

verfasst von: Erika Kuwahara, Keiko Asakura, Yuji Nishiwaki, Nagamu Inoue, Mamoru Watanabe, Toshifumi Hibi, Toru Takebayashi

Erschienen in: Journal of Gastroenterology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Although the prevalence of inflammatory bowel disease (IBD) is reported to have reached a plateau in Western countries, it is increasing in Asia. The etiology of IBD is still under investigation. We performed an epidemiological study to clarify the characteristics of IBD in Japan, focusing on patients’ family history.

Methods

We obtained clinical data on ulcerative colitis (UC) (46,114 cases) and Crohn’s disease (CD) (11,305 cases) in 2007 from an electronic database maintained under the Japanese Ministry of Health, Labour and Welfare’s nationwide registry system, and analyzed the differences in disease characteristics between patients with IBD who had a family history of the disease and those who did not.

Results

A total of 2.7% of the patients with UC and 2.6% of those with CD had a family history. The present age and age at disease onset were lower among the patients with UC who had a family history than among those without (present age: p < 0.001; age at disease onset: p < 0.001; Mann–Whitney U-test), but no similar trend was observed in the patients with CD. Disease severity was worse among both the UC and CD patients with a family history. The clinical course of patients with UC was not affected by family history. Levels of independence in daily life were associated with family history among CD patients, whereas age was associated with levels of independence in daily life among UC patients.

Conclusion

Disease characteristics of IBD vary in some aspects according to the presence or absence of a family history.
Literatur
1.
Zurück zum Zitat Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol. 2007;102:1077–83.PubMedCrossRef Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol. 2007;102:1077–83.PubMedCrossRef
2.
Zurück zum Zitat Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.PubMedCrossRef Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.PubMedCrossRef
3.
Zurück zum Zitat Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–40.PubMedCrossRef Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–40.PubMedCrossRef
4.
Zurück zum Zitat Goh K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis. 2009;10:1–6.PubMedCrossRef Goh K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis. 2009;10:1–6.PubMedCrossRef
5.
Zurück zum Zitat Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–65.PubMedCrossRef Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–65.PubMedCrossRef
6.
Zurück zum Zitat Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: Incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol. 1995;30(Suppl 8):5–8.PubMed Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: Incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol. 1995;30(Suppl 8):5–8.PubMed
7.
Zurück zum Zitat Ishige T, Tomomasa T, Takebayashi T, Asakura K, Watanabe M, Suzuki T, et al. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol. 2010;45:911–7.PubMedCrossRef Ishige T, Tomomasa T, Takebayashi T, Asakura K, Watanabe M, Suzuki T, et al. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol. 2010;45:911–7.PubMedCrossRef
8.
Zurück zum Zitat Ben-Horin S, Avidan B, Yanai H, Lang A, Chowers Y, Bar-Meir S. Familial clustering of Crohn’s disease in Israel: prevalence and association with disease severity. Inflamm Bowel Dis. 2009;15:171–5.PubMedCrossRef Ben-Horin S, Avidan B, Yanai H, Lang A, Chowers Y, Bar-Meir S. Familial clustering of Crohn’s disease in Israel: prevalence and association with disease severity. Inflamm Bowel Dis. 2009;15:171–5.PubMedCrossRef
9.
Zurück zum Zitat Carbonnel F, Macaigne G, Beaugerie L, Gendre JP, Cosnes J. Crohn’s disease severity in familial and sporadic cases. Gut. 1999;44:91–5.PubMedCrossRef Carbonnel F, Macaigne G, Beaugerie L, Gendre JP, Cosnes J. Crohn’s disease severity in familial and sporadic cases. Gut. 1999;44:91–5.PubMedCrossRef
10.
Zurück zum Zitat Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J. 1955;2:1041–8.PubMedCrossRef Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J. 1955;2:1041–8.PubMedCrossRef
11.
Zurück zum Zitat de Dombal F, Softley A. IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn’s disease. International Organisation for the Study of Inflammatory Bowel Disease. Gut. 1987;28(4):474–81.PubMedCrossRef de Dombal F, Softley A. IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn’s disease. International Organisation for the Study of Inflammatory Bowel Disease. Gut. 1987;28(4):474–81.PubMedCrossRef
12.
Zurück zum Zitat Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol. 2002;8:158–61.PubMed Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol. 2002;8:158–61.PubMed
13.
Zurück zum Zitat Park JB, Yang SK, Byeon JS, Park ER, Moon G, Myung SJ, et al. Familial occurrence of inflammatory bowel disease in Korea. Inflamm Bowel Dis. 2006;12:1146–51.PubMedCrossRef Park JB, Yang SK, Byeon JS, Park ER, Moon G, Myung SJ, et al. Familial occurrence of inflammatory bowel disease in Korea. Inflamm Bowel Dis. 2006;12:1146–51.PubMedCrossRef
14.
Zurück zum Zitat Monsén U, Broström O, Nordenvall B, Sörstad J, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol. 1987;22:214–8.PubMedCrossRef Monsén U, Broström O, Nordenvall B, Sörstad J, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol. 1987;22:214–8.PubMedCrossRef
15.
Zurück zum Zitat Monsén U, Bernell O, Johansson C, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with Crohn’s disease. Scand J Gastroenterol. 1991;26:302–6.PubMedCrossRef Monsén U, Bernell O, Johansson C, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with Crohn’s disease. Scand J Gastroenterol. 1991;26:302–6.PubMedCrossRef
16.
Zurück zum Zitat Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34:517–24.PubMedCrossRef Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34:517–24.PubMedCrossRef
17.
Zurück zum Zitat Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology. 1989;96:1016–20.PubMed Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology. 1989;96:1016–20.PubMed
18.
Zurück zum Zitat Farmer RG, Michener WM, Mortimer EA. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol. 1980;9:271–7.PubMed Farmer RG, Michener WM, Mortimer EA. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol. 1980;9:271–7.PubMed
19.
Zurück zum Zitat Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med. 1963;59:133–44.PubMed Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med. 1963;59:133–44.PubMed
20.
Zurück zum Zitat Lewkonia RM, McConnell RB. Progress report: familial inflammatory bowel disease: heredity or environment? Gut. 1976;17:235–41.PubMedCrossRef Lewkonia RM, McConnell RB. Progress report: familial inflammatory bowel disease: heredity or environment? Gut. 1976;17:235–41.PubMedCrossRef
21.
Zurück zum Zitat Tysk C, Lindberg E, Järnerot G, Flodérus-Myrhed B. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut. 1988;29:990–6.PubMedCrossRef Tysk C, Lindberg E, Järnerot G, Flodérus-Myrhed B. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut. 1988;29:990–6.PubMedCrossRef
22.
Zurück zum Zitat Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, et al. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci. 1995;40:814–8.PubMedCrossRef Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, et al. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci. 1995;40:814–8.PubMedCrossRef
23.
Zurück zum Zitat Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens. 1999;53:350–8.PubMedCrossRef Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens. 1999;53:350–8.PubMedCrossRef
24.
Zurück zum Zitat Myung SJ, Yang SK, Jung HY, Chang HS, Park B, Hong WS, et al. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study. Int J Colorectal Dis. 2002;17:233–7.PubMedCrossRef Myung SJ, Yang SK, Jung HY, Chang HS, Park B, Hong WS, et al. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study. Int J Colorectal Dis. 2002;17:233–7.PubMedCrossRef
25.
Zurück zum Zitat De La Concha EG, Fernandez-Arquero M, Santa-Cruz S, Lopez-Nava G, Figueredo MA, Diaz-Rubio M, et al. Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC). Clin Exp Immunol. 1997;108:392–5.CrossRef De La Concha EG, Fernandez-Arquero M, Santa-Cruz S, Lopez-Nava G, Figueredo MA, Diaz-Rubio M, et al. Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC). Clin Exp Immunol. 1997;108:392–5.CrossRef
26.
Zurück zum Zitat Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet. 1996;347:1212–7.PubMedCrossRef Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet. 1996;347:1212–7.PubMedCrossRef
27.
Zurück zum Zitat Cottone M, Bunce M, Taylor CJ, Ting A, Jewell DP. Ulcerative colitis and HLA phenotype. Gut. 1985;26:952–4.PubMedCrossRef Cottone M, Bunce M, Taylor CJ, Ting A, Jewell DP. Ulcerative colitis and HLA phenotype. Gut. 1985;26:952–4.PubMedCrossRef
28.
Zurück zum Zitat Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology. 2002;123:86–91.PubMedCrossRef Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology. 2002;123:86–91.PubMedCrossRef
29.
Zurück zum Zitat Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, et al. NOD2/CARD15 gene polymorphisms and Crohn’s disease in the Chinese population. Aliment Pharmacol Ther. 2003;17:1465–70.PubMedCrossRef Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, et al. NOD2/CARD15 gene polymorphisms and Crohn’s disease in the Chinese population. Aliment Pharmacol Ther. 2003;17:1465–70.PubMedCrossRef
30.
Zurück zum Zitat Croucher PJ, Mascheretti S, Hampe J, Huse K, Frenzel H, Stoll M, et al. Haplotype structure and association to Crohn’s disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet. 2003;11:6–16.PubMedCrossRef Croucher PJ, Mascheretti S, Hampe J, Huse K, Frenzel H, Stoll M, et al. Haplotype structure and association to Crohn’s disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet. 2003;11:6–16.PubMedCrossRef
31.
Zurück zum Zitat Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–6.PubMedCrossRef Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–6.PubMedCrossRef
32.
Zurück zum Zitat Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.PubMedCrossRef Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.PubMedCrossRef
33.
Zurück zum Zitat Annual report of the Research Committee of “intractable inflammatory bowel disease”, 1992. The Ministry of Health and Welfare of Japan, Tokyo; 1993 (in Japanese). Annual report of the Research Committee of “intractable inflammatory bowel disease”, 1992. The Ministry of Health and Welfare of Japan, Tokyo; 1993 (in Japanese).
34.
Zurück zum Zitat Aldhous MC, Drummond HE, Anderson N, Baneshi MR, Smith LA, Arnott ID, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol. 2007;102:589–97.PubMedCrossRef Aldhous MC, Drummond HE, Anderson N, Baneshi MR, Smith LA, Arnott ID, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol. 2007;102:589–97.PubMedCrossRef
35.
Zurück zum Zitat Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn’s disease. Inflamm Bowel Dis. 2004;10:521–8.PubMedCrossRef Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn’s disease. Inflamm Bowel Dis. 2004;10:521–8.PubMedCrossRef
Metadaten
Titel
Effects of family history on inflammatory bowel disease characteristics in Japanese patients
verfasst von
Erika Kuwahara
Keiko Asakura
Yuji Nishiwaki
Nagamu Inoue
Mamoru Watanabe
Toshifumi Hibi
Toru Takebayashi
Publikationsdatum
01.09.2012
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 9/2012
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0558-3

Weitere Artikel der Ausgabe 9/2012

Journal of Gastroenterology 9/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.